A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215

Autor: Rusconi, Stefano *, La Seta Catamancio, Simona, Sheridan, Francis, Parker, David
Zdroj: In Journal of Clinical Virology 2000 19(3):135-142
Databáze: ScienceDirect